1. Home
  2. MIST vs FCAP Comparison

MIST vs FCAP Comparison

Compare MIST & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • FCAP
  • Stock Information
  • Founded
  • MIST 2003
  • FCAP 1891
  • Country
  • MIST Canada
  • FCAP United States
  • Employees
  • MIST N/A
  • FCAP N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • FCAP Savings Institutions
  • Sector
  • MIST Health Care
  • FCAP Finance
  • Exchange
  • MIST Nasdaq
  • FCAP Nasdaq
  • Market Cap
  • MIST 145.3M
  • FCAP 125.9M
  • IPO Year
  • MIST N/A
  • FCAP 1999
  • Fundamental
  • Price
  • MIST $1.97
  • FCAP $44.02
  • Analyst Decision
  • MIST Strong Buy
  • FCAP
  • Analyst Count
  • MIST 3
  • FCAP 0
  • Target Price
  • MIST $6.33
  • FCAP N/A
  • AVG Volume (30 Days)
  • MIST 1.2M
  • FCAP 3.8K
  • Earning Date
  • MIST 11-11-2025
  • FCAP 10-24-2025
  • Dividend Yield
  • MIST N/A
  • FCAP 2.65%
  • EPS Growth
  • MIST N/A
  • FCAP 9.31
  • EPS
  • MIST N/A
  • FCAP 3.93
  • Revenue
  • MIST N/A
  • FCAP $44,673,000.00
  • Revenue This Year
  • MIST N/A
  • FCAP N/A
  • Revenue Next Year
  • MIST N/A
  • FCAP N/A
  • P/E Ratio
  • MIST N/A
  • FCAP $11.06
  • Revenue Growth
  • MIST N/A
  • FCAP 9.48
  • 52 Week Low
  • MIST $0.63
  • FCAP $28.50
  • 52 Week High
  • MIST $2.75
  • FCAP $53.85
  • Technical
  • Relative Strength Index (RSI)
  • MIST 67.34
  • FCAP 67.39
  • Support Level
  • MIST $1.75
  • FCAP $42.77
  • Resistance Level
  • MIST $1.83
  • FCAP $44.04
  • Average True Range (ATR)
  • MIST 0.09
  • FCAP 0.78
  • MACD
  • MIST 0.02
  • FCAP 0.34
  • Stochastic Oscillator
  • MIST 79.49
  • FCAP 98.47

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About FCAP First Capital Inc.

First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.

Share on Social Networks: